This Page Intentionally Left Blank - Int Medical

312 Ocular inflammation
20. Frucht-Pery J, Siganos CS, Solomon A, et al. Topical indomethacin solution
versus dexamethasone solution for treatment of inflamed pterygium and
pinguecula: a prospective randomized clinical study. Am J Ophthalmol.
1999;127(2):148–152.
21. Kosrirukvongs P. Topical piroxicam and conjunctivitis. J Med Assoc Thai.
1997;80(5):287–292.
22. Chung I, Buhr V. Topical ophthalmic drugs and the pediatric patient.
Optometry. 2000;71(8):511–518.
23. Rhee SS, Mah FS. Comparison of tobramycin 0.3%/dexamethasone 0.1% and
tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitis.
Adv Ther. 2007;24(1):60–67.
24. Keamy J, Umlas J, Lee Y. Red coral keratitis. Cornea. 2000;19(6): 859–860.
25. Grub M, Mielke J, Schlote T. [Bee sting of the cornea: a case report.] Klin
Monatsbl Augenheilkd. 2001;218(11):747–750.
26. Komericki P, Fellner P, El-Shabrawi Y, et al. Keratopathy after ultraviolet B
phototherapy. Wien Klin Wochenschr. 2005;117(7–8):300–302.
27. Majeed A, Naeem Z, Khan DA, et al. Epidemic adenoviral conjunctivitis report
of an outbreak in a military garrison and recommendations for its management
and prevention. J Pak Med Assoc. 2005;55(7):273–275.
28. Ganz M, Koll E, Gausche J, et al. Ketotifen fumarate and olopatadine hydrochloride
in the treatment of allergic conjunctivitis: a real-world comparison of
efficacy and ocular comfort. Adv Ther. 2003; 20(2):79–91.
29. Abelson MB, Chapin MJ, Kapik BM, et al. Ocular tolerability and safety of
ketotifen fumarate ophthalmic solution. Adv Ther. 2002;19(4): 161–169.
30. Bachert C, Brostoff J, Scadding GK, et al. Mizolastine therapy also has an effect
on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study
Group. Allergy. 1998;53(10):969–975.
31. Sodhi PK, Pandey RM, Ratan SK. Efficacy and safety of topical azelastine
compared with topical mitomycin C in patients with allergic conjunctivitis.
Cornea. 2003;22(3):210–213.
32. Dekaris I, Gabric N, Lazic R, et al. [Evaluation of the efficacy and safety of
lodoxamide in patients with allergic eye diseases.] Acta Med Croatica. 2002;56
(3):93–98.
33. Tauber J. Nedocromil sodium ophthalmic solution 2% twice daily in patients
with allergic conjunctivitis. Adv Ther. 2002;19(2):73–84.
34. van der Weele GM, Rietveld RP, Wiersma T, et al. [Summary of the
practice guideline “The red eye” (first revision) of the Dutch College